SCIENTIFIC PRESENTATIONS & PUBLICATIONS
85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®
June 22, 2025
A Twelve-Week Trial of MET-097—A Potent and Ultra-Long-Acting GLP-1 Receptor Agonist
Robert Stoekenbroek, Jenna Bisch, Sheela Kolluri, Mustafa Noor, Jason Mallory, Rory Cunningham, Brian Hubbard, and Steven P. Marso
Metsera, Inc. New York, NY and London, UK
Presenter
Robert Stoekenbroek
Poster #
788-P
Classification
Clinical